The case report comes 10 years after the first such case, known as the "Berlin Patient"

Current HIV therapy involves combinations of antiretroviral drugs, each of which inhibits a specific stage of the HIV lifecycle

The new vaccine strategy is based on the HIV envelope protein, Env

Researchers identify small molecule as potential treatment target

Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer, and other diseases

NIH scientists suspect process aims to curb immune-system hyperactivity

Genetic signatures trace the origin of infection and its potential path through populations, allowing state health departments to track the disease

New research shows that an experimental HIV-1 vaccine regimen is well-tolerated

Unlike conventional methods of HIV prevention, such as condoms or anti-HIV drugs, the recently-created implant takes advantage of some people’s natural immunity to the virus

Researchers have discovered that the Maraba virus can target and destroy HIV-infected cells that standard antiretroviral therapies can't reach